Raymond James’ investment-bank president wants to double the healthcare group’s revenue in 3 years as biotech remains hot
Raymond James’ top banker, Jim Bunn, explained why biotech is the key to the firm’s growth in healthcare. Here’s how he plans to capitalize on the hot biotech market.
Here’s T. Rowe Price’s gameplan for pushing further into the $7 trillion private-investing space
Chris Newman, head of the Americas for T. Rowe Price’s institutional business, spoke with Insider about the $1.6 trillion asset manager’s push into alternative investments, like private credit. Take an inside look at the firm’s strategy.
How JPMorgan is doubling down on digital investing with its robo-advisor acquisition
The firm is acquiring Nutmeg, a UK digital wealth manager with some £3.5 billion in assets. More on that here.
Leave a Reply
Leave a Reply
This site uses Akismet to reduce spam. Learn how your comment data is processed.
